期刊文献+

膜联蛋白A2和骨桥蛋白在乳腺癌组织的表达及其与乳腺癌生物学行为的关系 被引量:7

Relationship of annexin A2 and osteopontin expression and biological behaviors of breast cancer
原文传递
导出
摘要 目的 观察膜联蛋白A2(Annexin A2)和骨桥蛋白(Osteopontin,OPN)在乳腺癌组织中的表达,探讨两者与乳腺癌发生发展的关系.方法 应用免疫组织化学技术检测50例乳腺癌组织和癌旁组织中Annexin A2和OPN的表达水平,并分析两者与乳腺癌生物学行为的关系.结果 Annexin A2在乳腺癌组织中呈高表达82.00%,在癌旁组织呈低表达36.00%,两者差异有统计学意义(P<0.01),Annexin A2表达水平与乳腺癌组织学分级、TNM分期、淋巴结转移有关(P<0.01);OPN在乳腺癌组织中呈高表达74.00%,在癌旁组织呈低表达22.00%,两者差异有统计学意义(P<0.01),OPN表达水平与乳腺癌TNM分期、淋巴结转移有关(P<0.05).结论 Annexin A2和OPN的高表达可能与乳腺癌的生物学行为有关. Objective To investigate the expression of Annexin A2 and Osteopontin (OPN) in breast cancer tissues and its relationship with pathogenesis of breast cancer.Methods The expression of Annexin A2 and OPN was examined by using immunohistochemical method in 50 cases of human breast cancer tissues and non-cancerous adjacent breast tissues (5 cm away from the margin of breast cancer).Results The positive expression rate of Annexin A2 in breast cancer tissues was 82.00%,and that in non-cancerous adjacent breast tissues was 36.00% (P <0.01).The overexpression of Annexin A2 was related to histologic grade,TNM stage and lymph node metastasis (P < 0.05).The positive expression rate of OPN in breast cancer tissues was 74.00%,and that in non-cancerous adjacent breast tissues was 22.00% (P < 0.01).The expression of OPN was closely related with TNM stage and lymph node metastasis of breast cancer (P < 0.05).Conclusion The overexpression of Annexin A2 and OPN might be correlated with the biological behaviors of breast cancer.
作者 黄隽 苏榕
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第12期2688-2690,共3页 Chinese Journal of Experimental Surgery
关键词 膜联蛋白A2 骨桥蛋白 乳腺癌 Annexin A2 Osteopontin Breast carcinoma
  • 相关文献

参考文献9

二级参考文献28

共引文献26

同被引文献54

  • 1朱震,陈兵.CD166在非小细胞肺癌转移淋巴结中的表达及意义[J].山东医药,2013,53(37):56-57. 被引量:3
  • 2茅文斌,邵增务.骨桥蛋白与骨质疏松症研究进展[J].中国骨质疏松杂志,2007,13(3):204-207. 被引量:24
  • 3Zhao W, Wang L, Zhang L, et al. Differential expression of intraeellu- lar and secreted osteopontin isoforms by murine macrophages in re- sponse to toll-like receptor agonists [ J ]. J B iol Chem,2010,285 (27) : 20452 -20461.
  • 4Anborgh PH, Mutrie JC, Tuck AB, et al. Role of the metastasis-promo- ting protein osteopntin in the tumour microenvironment[ J ]. J Cell Mol Med,2010,14(8) :2037-22044.
  • 5Xu T,Tang J,Gu M,et al. Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge [ J ]. 2013,20 ( 5 ) : e406-e419.
  • 6Yang X,Qiu MT, Hu JW,et al. Association of interleukin-18 gene promoter -607 C > A and -137G > C polymorphisms with cancer risk : a meta-analysis of 26 studies [ J ]. PLoS One, 2013,8 ( 9 ) : e73671.
  • 7Tsai CW, Tsai MH, Shih LC, et al. Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan [ J]. Anticancer Res, 2013,33 ( 8 ) :3391-3396.
  • 8Gimba ER, Tilli TM. Hunmn osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways [ J ]. Cancer Lett, 2013, 331 ( 1 ) : 11-17.
  • 9Chen Y, Liu H, Wu W, et al. Osieopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis[ J]. J Exp Clin Cancer Res, 2013,32:45.
  • 10Lee TY,Lin JT,Wu CC, et al. Osteopontin promoter polymorphisms are assoeiated with suseeptibility to gastric cancer [ J ]. J Clin Gastroentero1,2013,47 (6) :e55-e59.

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部